A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus.
Chikatoshi KatadaShouko KomoriTsutomu YoshidaShogo KawakamiAkinori WatanabeKenji IshidoMizutomo AzumaTakuya WadaKei HosodaKeishi YamashitaNaoki HikiSatoshi TanabeHiromichi IshiyamaWasaburo KoizumiPublished in: Esophagus : official journal of the Japan Esophageal Society (2019)
Definitive CRT with cisplatin and etoposide or carboplatin and etoposide is a feasible treatment for the resectable SCNEC-E, and long-term survival can be achieved in some patients.
Keyphrases
- locally advanced
- rectal cancer
- phase ii study
- end stage renal disease
- ejection fraction
- squamous cell carcinoma
- radiation therapy
- newly diagnosed
- chronic kidney disease
- single cell
- cell therapy
- heart failure
- clinical trial
- atrial fibrillation
- patient reported
- phase iii
- cardiac resynchronization therapy
- left ventricular